Fulcrum Therapeutics Expects $240 Million Cash Position as of December 31, 2024
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) recently provided an update on its financial situation through an updated corporate presentation published on its website on January 13, 2025. While the comprehensive financial results for the fourth quarter and fiscal year ending December 31, 2024, are yet to be finalized, the company anticipates reporting approximately $240 million in […]
More Stories
ICE Houston Arrests Over 400 Illegal Immigrants Charged With or Convicted of Child Sex Offenses in 2025
By Naveen Athrappully During President Donald Trump’s first year in office, the Immigration and Customs Enforcement’s (ICE) Houston division arrested...
UK Prosecutors Charge Syrian Air Force Intelligence Officer With Torture, Murder
By Chris Summers A former officer in Syria’s air force intelligence appeared in court in London on March 10, charged...
Trump Says Cuba Could Face Friendly or Unfriendly US Takeover
By Kimberly Hayek President Donald Trump said on Monday that Cuba faces severe humanitarian challenges and suggested the possibility of...
US Existing Home Sales Rise Unexpectedly in February as Affordability Continues to Improve
By Mary Prenon U.S. existing home sales saw a 1.7 percent month-over-month increase in February to a seasonally adjusted annual...
5,000 Targets in Iran Struck During Operation Epic Fury, US Central Command Says
By Chris Summers The United States has struck more than 5,000 targets across Iran since the start of Operation Epic...
Netflix on the Renewal of Miss Governor for Season 2? Cast and Review
Political comedy dramas are difficult to get a positive response from the audience, as they try to mix serious topics...